Grape seed contains natural antioxidants called polyphenols that may help ward
off Alzheimer's Disease, according to researchers at the Mount Sinai School of
Medicine in New York City who write about their findings in a paper about to be
published in the Journal of Alzheimer's Disease.
Previous studies
have suggested that the small soluble clusters of A-beta protein, called
"oligomers", found in the brains of people with Alzheimer's, are what poison
brain cells and cause the memory loss associated with the disease. They also
have the same effect in mice bred to develop Alzheimer's.
Previous
research has also shown that grape seed polyphenolic extract (GSPE) stops A-beta
oligomers being formed in "test tubes", and it also reduces cognitive impairment
and the characteristic brain degeneration seen in mice bred to develop
Alzheimer's Disease.
For this study, Dr Giulio Maria Pasinetti, The
Saunder Family Professor in Neurology, and Professor of Psychiatry and
Geriatrics and Adult Development at Mount Sinai School of Medicine, and
colleagues, teamed up with researchers from the University of Minnesota, led by
Dr Karen Hsiao Ashe.
For five months, theyy gave GSPE to transgenic mice
bred to develop Alzheimer's Disease. After this time, they found the mice's
brains had significantly reduced levels of A-beta*56, a specific form of A-beta
oligomer previously implicated in the promotion of Alzheimer's disease memory loss. But levels of
other A-beta compounds remained unchanged.
Thus they concluded that GSPE
was a safe, low-cost intervention that can selectively lower levels of
memory-impairing A-beta oligomer in live subjects, and "strongly suggest that
GSPE should be further tested as a potential prevention and/or therapy for AD
[Alzheimer's Disease]".
Pasinetti told the press that:
"Since
naturally occurring polyphenols are also generally commercially available as
nutritional supplements and have negligible adverse events even after prolonged
periods of treatment, this new finding holds significant promise as a preventive
method or treatment, and is being tested in translational studies in Alzheimer's
disease patients."
Red wine also contains a lot of grape-derived
polyphenols.
However, Pasinetti and colleagues emphasized that before we
can use these polyphenols, we first have to identify a biomarker of disease that
would identify who might be at high risk for developing Alzheimer's.
"It
will be critical to identify subjects who are at high risk of developing
Alzheimer's disease, so that we can initiate treatments very early and possibly
even in asymptomatic patients," explained Pasinetti.
But he also said
patients who are already in the first stages of the disease may also benefit
from early intervention with such a treatment.
Funds from the National
Institutes of Health helped pay for the study and Pasinetti is a named inventor
of a pending patent application related to the study of Alzheimer's disease, and
would benefit from a share of the proceeds should a license be
granted.
"Grape Seed Polyphenolic Extract Specifically Decreases
A[beta]*56 in the Brains of Tg2576 Mice."
Peng Liu, Lisa J. Kemper,
Jun Wang, Kathleen R. Zahs, Karen H. Ashe, Giulio M. Pasinetti
JAD
2011, Volume 26, Number 4, IN PRESS
Additional source: The Mount
Sinai Hospital / Mount Sinai School of Medicine (via EurekAlert!).
_________________________________________________________________________________________________
Join Us @
Fat Loss Tips and Tricks Facebook
http://tinyurl.com/2akebzw
Ketogenic Diet Tips and Tricks Facebook
http://tinyurl.com/3pc6p7c
No comments:
Post a Comment